JRCT ID: jRCTs032230339
Registered date:11/09/2023
Clinical Research of Invisible light stimulation to dementia or mild cognitive impairment patients
Basic Information
Recruitment status | Recruiting |
---|---|
Health condition(s) or Problem(s) studied | Mild Alzheimer's disease and mild cognitive impairment due to Alzheimer's disease |
Date of first enrollment | 11/09/2023 |
Target sample size | 30 |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | transcranial near infrared light stimulation |
Outcome(s)
Primary Outcome | ADAS-Cog |
---|---|
Secondary Outcome | MMSE, CDR, DEMQOL, DEMQOL-Proxy, NPI-Q, ZBI, CGI-I, PGI-I, satisfaction, safety, blindedness |
Key inclusion & exclusion criteria
Age minimum | >= 60age old |
---|---|
Age maximum | <= 90age old |
Gender | Both |
Include criteria | (1)Subjects who are between 60 and 90 years old at the time of obtaining consent (2)Subjects who have a history of hospital visits at the facility where this study is conducted. (3)Subjects diagnosed with early-stage AD (mild AD or MCI due to AD) after a thorough examination at the facility where this study is conducted. (4)Subjects whose MMSE score is between 15 and 30 points. (5)Subjects who have a study partner who lives with the subject or regularly monitors the subject's condition. (6)Subjects or study partners who must be able fill out the online questionnaire and communicate with researchers with emails. (7) Subjects who are on the stable treatment for early-stage AD (drug and non-drug therapy for at least 4 weeks). (8) Subjects who are not expected to have major changes in their circumstances, such as planned adminission to hospitals, long travels, and moving. (9) Subjects who are capable to consent to this clinical research |
Exclude criteria | (1) Subjects whose cognitive decline is judged to be due to causes other than Alzheimer's disease (psychiatric disorders, intellectual disabilities, etc.) (2) Subjects who have not had head imaging (head CT or MRI) performed at the facility where the research is being conducted within the past year, and subjects who are deemed by the study physician to be inappropriate for neuromodulation based on head imaging and/or physical findings. (3) Subjects who are determined to participate in a new clinical trial or clinical research during the period of participation in this study. (4) Subjects whom study physicians deemed inappropriate to participate in the clinical trial. |
Related Information
Primary Sponsor | Inagawa Takuma |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Japan Society for the Promotion of Science |
Secondary ID(s) |
Contact
Public contact | |
Name | Yuma Yokoi |
Address | 4-1-1, Ogawahitgashicho, Kodaira, Tokyo Tokyo Japan 187-8551 |
Telephone | +81-42-341-2711 |
yyokoi@ncnp.go.jp | |
Affiliation | National Center of Neurology and Psychiatry |
Scientific contact | |
Name | Takuma Inagawa |
Address | 4-1-1, Ogawahigashicho, Kodaira, Tokyo Tokyo Japan 187-8551 |
Telephone | +81-42-341-2711 |
tinagawa@ncnp.go.jp | |
Affiliation | National Center of Neurology and Psychiatry |